{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:11:39Z","timestamp":1790201499766,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bpobgyn.2023.102436","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T17:33:52Z","timestamp":1700760832000},"page":"102436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Prediction of preeclampsia in asymptomatic women"],"prefix":"10.1016","volume":"92","author":[{"given":"Nikki M.W.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piya","family":"Chaemsaithong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liona C.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102436_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/AOG.0b013e3181a45b25","article-title":"Hypertensive disorders and severe obstetric morbidity in the United States","volume":"113","author":"Kuklina","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib3","series-title":"Obstetrics : normal and problem pregnancies","author":"Gabbe","year":"2017"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib4","series-title":"Hypertensive disorders in pregnancy","author":"Chesley","year":"1978"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib5","doi-asserted-by":"crossref","first-page":"582 e1","DOI":"10.1016\/j.ajog.2019.02.010","article-title":"Severe cardiovascular morbidity in women with hypertensive diseases during delivery hospitalization","volume":"220","author":"Ackerman","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/AOG.0b013e3181a45b25","article-title":"Hypertensive disorders and severe obstetric morbidity in the United States","volume":"113","author":"Kuklina","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"10022","key":"10.1016\/j.bpobgyn.2023.102436_bib7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"10204","key":"10.1016\/j.bpobgyn.2023.102436_bib8","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(19)31993-2","article-title":"Long-term cardiovascular health after stopping pre-eclampsia","volume":"394","author":"Staff","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib9","doi-asserted-by":"crossref","first-page":"74 e1","DOI":"10.1016\/j.ajog.2017.03.008","article-title":"Preeclampsia and cognitive impairment later in life","volume":"217","author":"Fields","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.earlhumdev.2016.09.007","article-title":"Preeclampsia; short and long-term consequences for mother and neonate","volume":"102","author":"Bokslag","year":"2016","journal-title":"Early Hum Dev"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102436_bib11","doi-asserted-by":"crossref","first-page":"395 e1","DOI":"10.1016\/j.ajog.2015.12.050","article-title":"The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia","volume":"214","author":"McKinney","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib12","doi-asserted-by":"crossref","first-page":"75 e1","DOI":"10.1016\/j.ajog.2019.07.024","article-title":"Risks of cause-specific mortality in offspring of pregnancies complicated by hypertensive disease of pregnancy","volume":"222","author":"Hammad","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102436_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"issue":"9741","key":"10.1016\/j.bpobgyn.2023.102436_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102436_bib15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.HYP.0000187899.34379.b0","article-title":"Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia","volume":"46","author":"Lam","year":"2005","journal-title":"Hypertension"},{"issue":"2S","key":"10.1016\/j.bpobgyn.2023.102436_bib16","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib17","first-page":"93","article-title":"Hypertensive disorders of pregnancy","volume":"78","author":"Leeman","year":"2008","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib18","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"Roberts","year":"2009","journal-title":"Placenta"},{"issue":"5728","key":"10.1016\/j.bpobgyn.2023.102436_bib19","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bpobgyn.2023.102436_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/297397","article-title":"Early prediction of preeclampsia","volume":"2014","author":"Poon","year":"2014","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2018.05.002","article-title":"The first-trimester of pregnancy - a window of opportunity for prediction and prevention of pregnancy complications and future life","author":"Poon","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib23","series-title":"Antenatal care: routine care for the healthy pregnant woman","year":"2008"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O'Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib25","series-title":"Hypertension in pregnancy: the management of hypertensive disorders during pregnancy","article-title":"National collaborating centre for women's and children's health (UK)","year":"2010"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib26","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"Low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib27","series-title":"WHO guidelines approved by the guidelines review committee","year":"2011"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102436_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.preghy.2014.01.003","article-title":"Canadian Hypertensive Disorders of Pregnancy Working G. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"4","author":"Magee","year":"2014","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"issue":"2S","key":"10.1016\/j.bpobgyn.2023.102436_bib30","doi-asserted-by":"crossref","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102436_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/jhh.2009.45","article-title":"Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach","volume":"24","author":"Poon","year":"2010","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib32","doi-asserted-by":"crossref","first-page":"i1753","DOI":"10.1136\/bmj.i1753","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102436_bib33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/HYPERTENSIONAHA.107.104646","article-title":"Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia","volume":"51","author":"Poon","year":"2008","journal-title":"Hypertension"},{"issue":"7653","key":"10.1016\/j.bpobgyn.2023.102436_bib35","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/bmj.39540.522049.BE","article-title":"Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis","volume":"336","author":"Cnossen","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/uog.14783","article-title":"Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history","volume":"45","author":"Wright","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib37","unstructured":"The Fetal Medicine Foundation. Preeclampsia screening."},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib38","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/uog.14789","article-title":"Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history","volume":"45","author":"Tayyar","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102436_bib39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/uog.5402","article-title":"Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia","volume":"32","author":"Plasencia","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/uog.6280","article-title":"First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia","volume":"33","author":"Poon","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102436_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/uog.13275","article-title":"First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women","volume":"43","author":"Velauthar","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102436_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/uog.14732","article-title":"Assessing quality standards in measurement of uterine artery pulsatility index at 11 to 13 + 6 weeks' gestation","volume":"46","author":"Ridding","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.bpobgyn.2023.102436_bib43","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1080\/14767058.2017.1341481","article-title":"Uterine artery pulsatility index in the first trimester: assessment of intersonographer and intersampling site measurement differences","volume":"31","author":"Chaemsaithong","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102436_bib44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/uog.18917","article-title":"Transverse technique: complementary approach to measurement of first-trimester uterine artery Doppler","volume":"52","author":"Drouin","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102436_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.bpobgyn.2023.102436_bib46","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000147365.86159.f5","article-title":"Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia","volume":"95","author":"Ahmad","year":"2004","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102436_bib47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/uog.6244","article-title":"Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia","volume":"32","author":"Akolekar","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102436_bib49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/uog.9029","article-title":"Longitudinal trends in fetoplacental biochemical markers, uterine artery pulsatility index and maternal blood pressure during the first trimester of pregnancy","volume":"38","author":"Wortelboer","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.preghy.2019.06.004","article-title":"Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor","volume":"17","author":"Cheng","year":"2019","journal-title":"Pregnancy Hypertens"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102436_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102436_bib52","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","article-title":"First-trimester prediction of hypertensive disorders in pregnancy","volume":"53","author":"Poon","year":"2009","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.bpobgyn.2023.102436_bib53","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/1471-0528.14029","article-title":"The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review","volume":"123","author":"Al-Rubaie","year":"2016","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib54","doi-asserted-by":"crossref","first-page":"62 e1","DOI":"10.1016\/j.ajog.2015.02.018","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"Wright","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102436_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.12.016","article-title":"Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting","volume":"208","author":"Scazzocchio","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102436_bib56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pd.4519","article-title":"First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors","volume":"35","author":"Crovetto","year":"2015","journal-title":"Prenat Diagn"},{"issue":"8","key":"10.1016\/j.bpobgyn.2023.102436_bib57","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.placenta.2011.05.006","article-title":"First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia","volume":"32","author":"Odibo","year":"2011","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102436_bib58","doi-asserted-by":"crossref","first-page":"514.e1","DOI":"10.1016\/j.ajog.2014.04.018","article-title":"Prediction of preeclampsia utilizing the first trimester screening examination","volume":"211","author":"Baschat","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.10.024","article-title":"First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume","volume":"218","author":"Sonek","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.01.020","article-title":"A new model for screening for early-onset preeclampsia","volume":"222","author":"Serra","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib62","doi-asserted-by":"crossref","first-page":"103 e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O'Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib63","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib64","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib65","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-130-6-199903160-00016","article-title":"Assessing the generalizability of prognostic information","volume":"130","author":"Justice","year":"1999","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102436_bib66","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5","article-title":"What do we mean by validating a prognostic model?","volume":"19","author":"Altman","year":"2000","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102436_bib67","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/uog.13433","article-title":"External validity of first-trimester algorithms in the prediction of pre-eclampsia disease severity","volume":"44","author":"Oliveira","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib68","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajo.12126","article-title":"Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy","volume":"53","author":"Park","year":"2013","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2023.102436_bib69","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/pd.2849","article-title":"Prospective evaluation of ultrasound and biochemical-based multivariable models for the prediction of late pre-eclampsia","volume":"31","author":"Farina","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib70","first-page":"1","article-title":"Validation of Fetal Medicine Foundation algorithm for prediction of pre-eclampsia in the first trimester in an unselected Brazilian population","author":"Lobo","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib71","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preghy.2019.05.006","article-title":"External validation of the Fetal Medicine Foundation algorithm for the prediction of preeclampsia in a Brazilian population","volume":"17","author":"Rezende","year":"2019","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib72","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/uog.17399","article-title":"Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation","volume":"49","author":"O'Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"13","key":"10.1016\/j.bpobgyn.2023.102436_bib73","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/1471-0528.13194","article-title":"Risk assessment for preeclampsia in nulliparous women at 11-13 weeks gestational age: prospective evaluation of two algorithms","volume":"122","author":"Skrastad","year":"2015","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102436_bib74","doi-asserted-by":"crossref","first-page":"383.e1","DOI":"10.1016\/j.ajog.2010.06.014","article-title":"Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women","volume":"203","author":"Audibert","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejogrb.2017.08.031","article-title":"External validation of preexisting first trimester preeclampsia prediction models","volume":"217","author":"Allen","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102436_bib76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/10641955.2019.1584210","article-title":"External validation of prognostic models for preeclampsia in a Dutch multicenter prospective cohort","volume":"38","author":"Lamain-de Ruiter","year":"2019","journal-title":"Hypertens Pregnancy"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib77","doi-asserted-by":"crossref","first-page":"650 e1","DOI":"10.1016\/j.ajog.2019.09.041","article-title":"Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population","volume":"221","author":"Chaemsaithong","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.bpobgyn.2023.102436_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/uog.20105","article-title":"ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia","volume":"53","author":"Sotiriadis","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102436_bib80","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3109\/14767058.2011.602140","article-title":"First trimester serum markers stability during sample transportation from the obstetrical site to the screening laboratory","volume":"25","author":"Sahota","year":"2012","journal-title":"J Matern Fetal Neonatal Med : Off J Eur Assoc Perinat Med Fed Asia Oceania Perinat Soc Int Soc Perinat Obstet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib81","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000335366","article-title":"Protocol for measurement of mean arterial pressure at 11-13 weeks' gestation","volume":"31","author":"Poon","year":"2012","journal-title":"Fetal Diagn Ther"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102436_bib82","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/uog.12366","article-title":"How to record uterine artery Doppler in the first trimester","volume":"42","author":"Khalil","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/FM9.0000000000000005","article-title":"Screening and prevention of preeclampsia","volume":"1","author":"Poon","year":"2019","journal-title":"Mater Fetal Med"},{"issue":"8","key":"10.1016\/j.bpobgyn.2023.102436_bib84","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/1471-0528.12613","article-title":"Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary","volume":"121","author":"Hofmeyr","year":"2014","journal-title":"BJOG"},{"issue":"10060","key":"10.1016\/j.bpobgyn.2023.102436_bib85","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bpobgyn.2023.102436_bib86","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","article-title":"Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial","volume":"3","author":"Chiswick","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib87","series-title":"Metformin for the prevention of hypertensive disorders of pregnancy in women with gestational diabetes and obesity: a systematic review and meta-analysis","author":"Kalafat","year":"2018"},{"issue":"17","key":"10.1016\/j.bpobgyn.2023.102436_bib88","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa054186","article-title":"Vitamins C and E and the risks of preeclampsia and perinatal complications","volume":"354","author":"Rumbold","year":"2006","journal-title":"N Engl J Med"},{"issue":"2S","key":"10.1016\/j.bpobgyn.2023.102436_bib89","doi-asserted-by":"crossref","first-page":"S1126","DOI":"10.1016\/j.ajog.2020.11.006","article-title":"Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis","volume":"226","author":"Cruz-Lemini","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"21","key":"10.1016\/j.bpobgyn.2023.102436_bib90","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/bjsports-2018-099355","article-title":"Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis","volume":"52","author":"Davenport","year":"2018","journal-title":"Br J Sports Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102436_bib91","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"2S","key":"10.1016\/j.bpobgyn.2023.102436_bib92","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib93","doi-asserted-by":"crossref","first-page":"685 e1","DOI":"10.1016\/j.ajog.2017.08.110","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia","volume":"217","author":"Wright","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102436_bib94","doi-asserted-by":"crossref","first-page":"612 e1","DOI":"10.1016\/j.ajog.2018.02.014","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit","volume":"218","author":"Wright","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102436_bib95","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102436_bib96","doi-asserted-by":"crossref","first-page":"619 e1","DOI":"10.1016\/j.ajog.2015.11.016","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation","volume":"214","author":"Gallo","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102436_bib97","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/uog.23640","article-title":"Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation","volume":"58","author":"Litwinska","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/uog.24789","article-title":"STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35-37 weeks' gestation","volume":"59","author":"Dobert","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib99","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12913-018-3406-1","article-title":"Economic assessment of the use of the sFlt-1\/PlGF ratio test to predict preeclampsia in Germany","volume":"18","author":"Schlembach","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102436_bib100","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","article-title":"Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia","volume":"50","author":"Li","year":"2007","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102436_bib101","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.2015020157","article-title":"Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia","volume":"27","author":"Thadhani","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bpobgyn.2023.102436_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2023.03.032","article-title":"Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis","author":"Chaemsaithong","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102436_bib103","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.17418","article-title":"Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation","volume":"50","author":"Litwinska","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102436_bib104","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/uog.17419","article-title":"Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 35-37 weeks' gestation","volume":"50","author":"Panaitescu","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102436_bib105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/uog.21869","article-title":"From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach","volume":"55","author":"Poon","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"19","key":"10.1016\/j.bpobgyn.2023.102436_bib106","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102436_bib107","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia: inspire","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertension"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693423001438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693423001438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:15:58Z","timestamp":1761498958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693423001438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":106,"alternative-id":["S1521693423001438"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2023.102436","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of preeclampsia in asymptomatic women","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2023.102436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102436"}}